科华智慧（深圳）创新药物研发有限公司-天然产物化合物库-创新药物研发-波谱智能解析-化合物冷冻电镜结构解析

天然产物数据库

您可快速检索70万⁺天然产物信息

检索最多: 白僵菌素大品种冬虫夏草人参三七党参大戟决明半夏丁香

CAS No.	英文名/中文名/SMILES	分子式	分子量
-	Rhizoxin S1 - C[C@@H]1/C=C/[C@@H]2[C@](O2)([C@H](C[C@H](OC(=O)/C=C/C[C@H](C[C@H]1O)CC(=O)O)[C@H](C)[C@H](/C(=C/C=C/C(=C/C3=COC(=N3)C)/C)/C)O)O)C	C₃₄H₄₇NO₉	613.7
60454-77-5	Funkioside C - C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)C)C)C)OC1	C₃₉H₆₂O₁₃	738.9
-	[6-butyl-3-(2-methyl-1,3-thiazol-4-yl)-4-oxochromen-7-yl] (2R)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate - CCCCC1=CC2=C(C=C1OC(=O)[C@@H](C)NC(=O)OC(C)(C)C)OC=C(C2=O)C3=CSC(=N3)C	C₂₅H₃₀N₂O₆S	486.6
-	[(3S,5R,8R,9R,10S,13R,14S,16S,17R)-3-[(2R,3R,4S,5R,6R)-3-acetyloxy-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] acetate - C[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@H]3CC[C@]5([C@@]4(C[C@@H]([C@@H]5C6=CC(=O)OC6)OC(=O)C)O)C)C)OC(=O)C)OC)O	C₃₄H₅₀O₁₁	634.8
-	(3S,4R,5S,6R,8S,9S,10S,13R,14R,15S,17R)-3-[(2R,3S,4R,5S)-4-hydroxy-3,5-dimethoxyoxan-2-yl]oxy-17-[(2R,5S)-5-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-1,2,3,4,5,6,7,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-4,6,8,15-tetrol - C[C@H](CC[C@@H](C(C)C)O)[C@H]1C[C@@H]([C@H]2[C@@]1(CC[C@@H]3[C@]2(C[C@H]([C@@H]4[C@@]3(CC[C@@H]([C@@H]4O)O[C@@H]5[C@H]([C@@H]([C@H](CO5)OC)O)OC)C)O)O)C)O	C₃₄H₆₀O₁₀	628.8
-	(1R,2S,4R,6R,7R,8S,9R,12R,13S,16S,18R)-16-[(2S,3S,4S,5R,6S)-5-[(2R,3S,4R,5S,6S)-3-[(2R,3S,4R,5S,6S)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2R,3S,4R,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3S,4R,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxy-7,9,13-trimethyl-6-[(3R)-3-methyl-4-[(2S,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosan-10-one - C[C@@H]1[C@@H]2[C@@H](C[C@@H]3[C@]2(C(=O)C[C@@H]4[C@H]3CC[C@H]5[C@@]4(CC[C@@H](C5)O[C@@H]6[C@H]([C@@H]([C@H]([C@@H](O6)CO)O[C@@H]7[C@H]([C@@H]([C@H]([C@@H](O7)CO)O)O[C@@H]8[C@H]([C@@H]([C@H](CO8)O)O)O)O[C@@H]9[C@H]([C@@H]([C@H]([C@@H](O9)CO)O)O[C@@H]2[C@H]([C@@H]([C@H](CO2)O)O)O)O)O)O)C)C)O[C@@]1(CC[C@@H](C)CO[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CO)O)O)O)O	C₆₁H₁₀₀O₃₃	1361.4
-	(2S)-2-[[(2R)-2-(4-ethyl-2-oxochromen-7-yl)oxypropanoyl]amino]propanoic acid - CCC1=CC(=O)OC2=C1C=CC(=C2)O[C@H](C)C(=O)N[C@@H](C)C(=O)O	C₁₇H₁₉NO₆	333.3
-	(5S)-8-hydroxy-2,2,5-trimethyl-5-(3-methylbut-2-enyl)-7-(3-phenylpropanoyl)chromen-6-one - CC(=CC[C@]1(C2=C(C(=C(C1=O)C(=O)CCC3=CC=CC=C3)O)OC(C=C2)(C)C)C)C	C₂₆H₃₀O₄	406.5
-	(3S,10S,13R,14R,17R)-10,13-dimethyl-17-[(E,2R)-5-methylhex-3-en-2-yl]-2,3,4,12,14,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-3-ol - C[C@H](/C=C/C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC=C3C2=CC=C4[C@@]3(CC[C@@H](C4)O)C)C	C₂₆H₃₈O	366.6
-	(1R,4aR,5S,8aR)-1,4a,6-trimethyl-5-[2-(5-oxo-2H-furan-4-yl)ethyl]-2,3,4,5,8,8a-hexahydronaphthalene-1-carboxylic acid - CC1=CC[C@@H]2[C@@]([C@H]1CCC3=CCOC3=O)(CCC[C@@]2(C)C(=O)O)C	C₂₀H₂₈O₄	332.4